WASHINGTON (AP) -- Federal health officials said Monday a highly-anticipated drug to treat hepatitis C made by Merck appears to cure more patients in less time than established drugs that have been used for 20 years. But the agency has questions about how the drug should be combined with older medicines for the maximum effect....

Topics:  washington ap     federal   merck   drug   hepatitis   
BING NEWS:
  • Exclusive: US FDA finds widely used asthma drug impacts the brain
    Singulair binds to brain receptors affecting psychiatric functions Merck spinoff Organon confident in Singulair's safety profile FDA has no plan to update drug label based on new data Nov 22 ...
    11/21/2024 - 10:59 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News